Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 3
2016 3
2017 3
2018 3
2019 3
2020 4
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
Molecular profiles of benign and (pre)malignant endometrial lesions.
van der Putten LJM, van Hoof R, Tops BBJ, Snijders MPLM, van den Berg-van Erp SH, van der Wurff AAM, Bulten J, Pijnenborg JMA, Massuger LFAG. van der Putten LJM, et al. Carcinogenesis. 2017 Mar 1;38(3):329-335. doi: 10.1093/carcin/bgx008. Carcinogenesis. 2017. PMID: 28203752
Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer.
Vrede SW, van Weelden WJ, Visser NCM, Bulten J, van der Putten LJM, van de Vijver K, Santacana M, Colas E, Gil-Moreno A, Moiola CP, Mancebo G, Krakstad C, Trovik J, Haldorsen IS, Huvila J, Koskas M, Weinberger V, Bednarikova M, Hausnerova J, van der Wurff AA, Matias-Guiu X, Amant F; ENITEC Consortium, Snijders MPLM, Küsters-Vandevelde HVN, Reijnen C, Pijnenborg JMA. Vrede SW, et al. Among authors: van der putten ljm. Gynecol Oncol. 2021 Jun;161(3):787-794. doi: 10.1016/j.ygyno.2021.03.031. Epub 2021 Apr 12. Gynecol Oncol. 2021. PMID: 33858677 Free article.
Reproducibility of measurement of myometrial invasion in endometrial carcinoma.
van der Putten LJ, van de Vijver K, Bartosch C, Davidson B, Gatius S, Matias-Guiu X, McCluggage WG, Toledo G, van der Wurff AA, Pijnenborg JM, Massuger LF, Bulten J. van der Putten LJ, et al. Virchows Arch. 2017 Jan;470(1):63-68. doi: 10.1007/s00428-016-2035-5. Epub 2016 Oct 27. Virchows Arch. 2017. PMID: 27787595 Free PMC article.
Oestrogen receptor pathway activity is associated with outcome in endometrial cancer.
van Weelden WJ, van der Putten LJM, Inda MA, van Brussel A, Snijders MPLM, Schriever LMM, Bulten J, Massuger LFAG, van de Stolpe A, Pijnenborg JMA. van Weelden WJ, et al. Among authors: van der putten ljm. Br J Cancer. 2020 Sep;123(5):785-792. doi: 10.1038/s41416-020-0925-4. Epub 2020 Jun 8. Br J Cancer. 2020. PMID: 32507853 Free PMC article.
Immunohistochemical Profiles of Endometrioid Endometrial Carcinomas With and Without Metastatic Disease.
Geels YP, van der Putten LJM, van Tilborg AAG, Nienhaus BEC, van den Berg-van Erp SH, Snijders MPLM, van der Wurff A, Massuger LFAG, Bulten J, Pijnenborg JMA. Geels YP, et al. Among authors: van der putten ljm. Appl Immunohistochem Mol Morphol. 2018 Mar;26(3):173-179. doi: 10.1097/PAI.0000000000000402. Appl Immunohistochem Mol Morphol. 2018. PMID: 27299188
Mutational analysis of cervical cytology improves diagnosis of endometrial cancer: A prospective multicentre cohort study.
Reijnen C, van der Putten LJM, Bulten J, Snijders MPLM, Küsters-Vandevelde HVN, Sweegers S, Vos MC, van der Wurff AAM, Ligtenberg MJL, Massuger LFAG, Eijkelenboom A, Pijnenborg JMA. Reijnen C, et al. Among authors: van der putten ljm. Int J Cancer. 2020 May 1;146(9):2628-2635. doi: 10.1002/ijc.32686. Epub 2019 Nov 22. Int J Cancer. 2020. PMID: 31523803 Free article.
L1CAM expression in endometrial carcinomas: an ENITEC collaboration study.
van der Putten LJ, Visser NC, van de Vijver K, Santacana M, Bronsert P, Bulten J, Hirschfeld M, Colas E, Gil-Moreno A, Garcia A, Mancebo G, Alameda F, Trovik J, Kopperud RK, Huvila J, Schrauwen S, Koskas M, Walker F, Weinberger V, Minar L, Jandakova E, Snijders MP, van den Berg-van Erp S, Matias-Guiu X, Salvesen HB, Amant F, Massuger LF, Pijnenborg JM. van der Putten LJ, et al. Br J Cancer. 2016 Sep 6;115(6):716-24. doi: 10.1038/bjc.2016.235. Epub 2016 Aug 9. Br J Cancer. 2016. PMID: 27505134 Free PMC article.
18 results